← Back to patent-cliff list
CAS 1085337-38-7
(R)-N-benzyl-3-hydroxy-2-(tritylamino)propanamide
Codes: LACO-007
Application context (from source-drug indications)
Tonic-clonic seizureLacosamideEpilepsyLacosamidePartial-onset seizureLacosamideSeizureLacosamide
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lacosamide | Tier B — Position early | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
D-serine→(chloromethanetriyl)tribenzene→trityl-D-serine→phenylmethanamine→(R)-N-benzyl-3-hydroxy-2-(tritylamino)propanamide→(R)-N-benzyl-3-methoxy-2-(tritylamino)propanamide→(R)-2-amino-N-benzyl-3-methoxypropanamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.